ETV stands for endoscopic third ventriculostomy, a surgical procedure used to treat hydrocephalus, the buildup of cerebrospinal fluid (CSF) in the brain. Instead of implanting a permanent drainage device, a neurosurgeon creates a small opening in the floor of one of the brain’s fluid chambers, allowing trapped fluid to flow around the blockage and be reabsorbed naturally. It is the preferred treatment for obstructive hydrocephalus, the type caused by a physical blockage in the brain’s fluid pathways.
How CSF Buildup Leads to ETV
Your brain constantly produces cerebrospinal fluid, which cushions the brain and spinal cord. This fluid circulates through four connected chambers called ventricles, then gets absorbed into the bloodstream. When something blocks that flow, such as a narrowed passage, a tumor, or a cyst, fluid backs up in the ventricles. The resulting pressure can cause headaches, vision problems, balance issues, and in infants, an enlarging head.
ETV bypasses the blockage entirely. Rather than rerouting fluid to another part of the body (which is what a shunt does), it creates an internal detour so fluid drains from the third ventricle directly into the spaces surrounding the brain, where it can be absorbed normally.
What Happens During the Procedure
The surgeon makes a small hole in the skull, roughly 2.5 to 3 centimeters from the midline near the front of the head. Through this opening, a thin, flexible camera called a neuroendoscope is guided into the brain’s ventricles. The scope passes through a natural opening between chambers (the foramen of Monro) to reach the floor of the third ventricle.
Once there, the surgeon identifies the thinnest point on the ventricle floor and creates a small perforation. This new opening allows CSF to flow downward into the fluid-filled spaces below the brain, bypassing whatever is causing the obstruction. No implant or hardware is left behind.
Who Benefits Most From ETV
ETV works best when the hydrocephalus is caused by a clear physical blockage. In a study of outcomes one year after surgery, patients whose hydrocephalus was caused by a narrowed aqueduct (the passage connecting the third and fourth ventricles) had the highest success rate at 89%. Patients with tumors or cysts blocking fluid flow also did well, with success rates of 84% and 82%, respectively.
The procedure is less effective when hydrocephalus results from infection or bleeding in the brain. In those cases, the success rate dropped to about 50%, because the problem is often not a single blockage but widespread scarring that interferes with fluid absorption. For this reason, ETV is not typically recommended as a first-line treatment for communicating hydrocephalus, where fluid flows freely between ventricles but isn’t absorbed properly.
ETV Compared to Shunts
The traditional alternative to ETV is a ventriculoperitoneal (VP) shunt, a tube-and-valve system that drains excess fluid from the brain into the abdomen. Shunts have been the standard treatment for decades and remain necessary for many patients, but they come with significant long-term drawbacks. The tubing can become blocked or infected, and many patients need multiple revision surgeries over their lifetime.
A systematic review comparing the two approaches in pediatric patients found meaningful differences. Infection rates were 0.02% for ETV compared to 0.1% for shunts. Reoperation rates were 0.05% for ETV versus 0.3% for shunts. Mortality rates were also lower with ETV (0.01% versus 0.05%). The key advantage is that ETV leaves no foreign material in the body, eliminating the ongoing risk of hardware malfunction or infection that comes with living with a shunt.
That said, overall failure rates for both procedures were similar at about 0.2%, meaning ETV doesn’t work for everyone. Some patients who undergo ETV eventually need a shunt placed anyway.
Predicting Whether ETV Will Work
Neurosurgeons use a tool called the ETV Success Score (ETVSS) to estimate how likely the procedure is to succeed for a specific patient. The score is calculated from three factors: the patient’s age at surgery, the cause of the hydrocephalus, and whether the patient has had a previous shunt. Higher scores predict better outcomes. In clinical validation, the score correctly predicted success with 84% sensitivity and 89% specificity, making it a reliable planning tool.
Age plays a particularly important role. Infants under three months have notably lower success rates, around 33%, compared to older infants and children, who see rates closer to 46%. This is partly because very young infants have immature fluid absorption pathways. For babies under three months, many surgeons do not recommend ETV as a first option.
Risks and Complications
ETV is considered a safe procedure, but it does carry risks because it involves working near critical brain structures. A systematic review of complications found that permanent complications occurred in about 2.1% of cases. Neurological issues like weakness on one side of the body, eye movement problems, or memory changes accounted for 1.2%. Hormonal and metabolic complications from the nearby hypothalamus, including fluid balance problems or weight gain, occurred in 0.9%.
Bleeding during the procedure happened in 3.9% of cases, though severe bleeding was rare at 0.6%. The most serious risk, rupture of the basilar artery (a major blood vessel sitting just below the perforation site), occurred in only 0.14% of cases.
Recovery and Follow-Up
Hospital stays after ETV are generally short, and most patients notice improvement in their symptoms within the first few days. Follow-up brain imaging, typically an MRI, is used to confirm that the new opening is working and fluid levels are decreasing. Early follow-up scans may happen within the first few weeks, with longer-term imaging at several months to verify that the opening remains patent.
Unlike shunts, which can fail at any time throughout a patient’s life due to mechanical problems, ETV failure tends to follow a recognizable pattern. If the opening heals shut, symptoms of rising brain pressure return. In infants, this may look like a bulging soft spot on the head or abnormal eye movements. In older children and adults, returning headaches, nausea, vision changes, or balance problems are the key warning signs. Most failures happen in the first weeks to months, but very late closures can occur years later. Patients and caregivers should know the original symptoms of hydrocephalus and seek urgent medical attention if those symptoms return.